News

We offer a complete package — also for the media.

Good news and important updates – stay informed in our News section

Conference

Delta G Avaris at the Global Solutions Summit 2026: Advancing Dialogue on Global Health, Prevention, and Innovation

Delta G Avaris was proud to participate in the Global Solutions Summit 2026, held in Berlin, Germany.

June 2026

Company News

Delta G Avaris acquires GMP production site of Richter Biologics in Hannover for phage manufacturing

Effective May 1, 2026, Delta G Avaris has acquired the GMP production site of Richter Biologics in Hannover, expanding its bacteriophage manufacturing capabilities.

05/01/2026

Conference

Participation at ESCMID Global 2026: Advances in Phage Therapy from Hannover

Hannover Medical School presented current results on the clinical application of bacteriophages at the ESCMID Global Congress in Munich.

04/22/2026

Research & Development

Delta G Avaris receives approximately €900,000 in research funding for the further development of phage therapy

Funding of approximately €900,000 for research and development activities in the field of phage therapy.

04/07/2026

Media Coverage

WISO report by ZDF

Be inspired by the fascinating capabilities of phage therapy - in the interview from minute 16:22 to 22:02.

10/27/2025

Contact

Press Contact

For press inquiries and media inquiries, please contact our communications department.